Genetic bases of the nutritional approach to migraine

References

• Anttila, V., H. Stefansson, M. Kallela, U. Todt, G. M. Terwindt, M. S. Calafato, D. R. Nyholt, A. S. Dimas, T. Freilinger, B. Muller-Myhsok, et al. 2010. Genome-wide association study of migraine implicates a common susceptibility variant on 8q22.1. Nature Genetics 42:869–73.
   PubMed Web of Science ®Google Scholar
• Banner, S. J., A. E. Fray, P. G. Ince, M. Steward, M. R. Cookson, and P. J. Shaw. 2002. The expression of the glutamate re-uptake transporter excitatory amino acid transporter 1 (EAAT1) in the normal human CNS and in motor neurone disease: an immunohistochemical study. Neuroscience 109:27–44.
   PubMed Web of Science ®Google Scholar
• Bodmer, S., C. Imark, and M. Kneubuhl. 1999. Biogenic amines in foods: histamine and food processing. Inflammation Research 48:296–300.
   PubMed Web of Science ®Google Scholar
• Boehnke, C., U. Reuter, U. Flach, S. Schuh-Hofer, K. M. Einhaupl, and G. Arnold. 2004. High-dose riboflavin treatment is efficacious in migraine prophylaxis: an open study in a tertiary care centre. European Journal of Neurology 11:475–77.
   PubMed Web of Science ®Google Scholar
• Burstein, R., R. Noseda, and D. Borsook. 2015. Migraine: multiple processes, complex pathophysiology. Journal of Neuroscience 35:6619–29.
   PubMed Web of Science ®Google Scholar
• Butun, A., M. Naziroglu, S. Demirci, O. Celik, and A. C. Uguz. 2015. Riboflavin and vitamin E increase brain calcium and antioxidants, and microsomal calcium-ATP-ase values in rat headache models induced by glyceryl trinitrate. Journal of Membrane Biology 248:205–13.
   PubMed Web of Science ®Google Scholar
• Carreno, O., R. Corominas, J. Fernandez-Morales, M. Camina, M. J. Sobrido, J. M. Fernandez-Fernandez, P. Pozo-Rosich, B. Cormand, and A. Macaya. 2012. SNP variants within the vanilloid TRPV1 and TRPV3 receptor genes are associated with migraine in the Spanish population. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics 159B:94–103.
   PubMed Web of Science ®Google Scholar
• Chasman, D. I., M. Schurks, V. Anttila, B. de Vries, U. Schminke, L. J. Launer, G. M. Terwindt, A. M. van den Maagdenberg, K. Fendrich, et al. 2011. Genome-wide association study reveals three susceptibility loci for common migraine in the general population. Nature Genetics 43:695–98.
   PubMed Web of Science ®Google Scholar
• Cianchetti, C. 2010. Capsaicin jelly against migraine pain. International Journal of Clinical Practice 64:457–59.
   PubMed Web of Science ®Google Scholar
• Clifford, R. F. 1997. Food and headache. Headache 8:319–29.
   Web of Science ®Google Scholar
• Colson, N. J., R. A. Lea, S. Quinlan, and L. R. Griffiths. 2006. No role for estrogen receptor 1 gene intron 1 Pvu II and exon 4 C325G polymorphisms in migraine susceptibility. Bmc Medical Genetics [Electronic Resource] 7:12.
   PubMed Web of Science ®Google Scholar
• Colson, N. J., R. A. Lea, S. Quinlan, J. MacMillan, and L. R. Griffiths. 2004. The estrogen receptor 1 G594A polymorphism is associated with migraine susceptibility in two independent case/control groups. Neurogenetics 5:129–33.
   PubMed Web of Science ®Google Scholar
• Corominas, R., M. Ribases, E. Cuenca-Leon, B. Cormand, and A. Macaya. 2009. Lack of association of hormone receptor polymorphisms with migraine. European Journal of Neurology 16:413–15.
   PubMed Web of Science ®Google Scholar
• Cowan, J., C. M. Sinton, A. W. Varley, F. H. Wians, R. W. Haley, and R. S. Munford. 2001. Gene therapy to prevent organophosphate intoxication. Toxicology and Applied Pharmacology 173:1–6.
   PubMed Web of Science ®Google Scholar
• Dale, H. H., and P. P. Laidlaw. 1910. The physiological action of beta-iminazolylethylamine. Journal of Physiology 41:318–44.
   PubMedGoogle Scholar
• Eagle, K. 2012. Toxicological effects of red wine, orange juice, and other dietary SULT1A inhibitors via excess catecholamines. Food and Chemical Toxicology 50:2243–49.
   PubMed Web of Science ®Google Scholar
• Eriksson, C. J., T. Fukunaga, T. Sarkola, W. J. Chen, C. C. Chen, J. M. Ju, A. T. Cheng, H. Yamamoto, K. Kohlenberg-Muller, M. Kimura, et al. 2001. Functional relevance of human adh polymorphism. Alcoholism, Clinical and Experimental Research 25:157S–63S.
   PubMed Web of Science ®Google Scholar
• Fenech, M., A. El-Sohemy, L. Cahill, L. R. Ferguson, T. A. French, E. S. Tai, J. Milner, W. P. Koh, L. Xie, M. Zucker, M. Buckley, et al. 2011. Nutrigenetics and nutrigenomics: viewpoints on the current status and applications in nutrition research and practice. Journal Nutrigenet Nutrigenomics 4:69–89.
   PubMed Web of Science ®Google Scholar
• Ferroni, P., P. Barbanti, D. Della-Morte, R. Palmirotta, E. Jirillo, and F. Guadagni. 2017. Redox Mechanisms in Migraine: Novel Therapeutics and Dietary Interventions. Antioxid Redox Signal. Published Online: 21 Nov 2017.
   PubMed Web of Science ®Google Scholar
• Formicola, D., A. Aloia, S. Sampaolo, O. Farina, D. Diodato, L. R. Griffiths, F. Gianfrancesco, G. Di Iorio, and T. Esposito. 2010. Common variants in the regulative regions of GRIA1 and GRIA3 receptor genes are associated with migraine susceptibility. BMC Medical Genetics [Electronic Resource] 11:103.
   PubMed Web of Science ®Google Scholar
• Garcia-Martin, E., C. Martinez, M. Serrador, H. Alonso-Navarro, P. Ayuso, F. Navacerrada, J. A. Agundez, and F. J. Jimenez-Jimenez. 2015. Diamine oxidase rs10156191 and rs2052129 variants are associated with the risk for migraine. Headache 55:276–86.
   PubMed Web of Science ®Google Scholar
• Garcia-Martin, E., C. Martinez, M. Serrador, H. Alonso-Navarro, F. Navacerrada, J. A. Agundez, and F. J. Jimenez-Jimenez. 2008. Histamine-N-methyl transferase polymorphism and risk for migraine. Headache 48:1343–48.
   PubMed Web of Science ®Google Scholar
• Garcia-Martin, E., C. Martinez, M. Serrador, H. Alonso-Navarro, F. Navacerrada, J. A. Agundez, and F. J. Jimenez-Jimenez. 2010a. Alcohol dehydrogenase 2 genotype and risk for migraine. Headache 50:85–91.
   PubMed Web of Science ®Google Scholar
• Garcia-Martin, E., C. Martinez, M. Serrador, H. Alonso-Navarro, F. Navacerrada, J. A. Agundez, and F. J. Jimenez-Jimenez. 2010b. Paraoxonase 1 (PON1) polymorphisms and risk for migraine. Journal of Neurology 257:1482–85.
   PubMed Web of Science ®Google Scholar
• Gaul, C., H. C. Diener, U. Danesch, and G. Migravent Study. 2015. Improvement of migraine symptoms with a proprietary supplement containing riboflavin, magnesium and Q10: a randomized, placebo-controlled, double-blind, multicenter trial. Journal Headache Pain 16:516.
   PubMed Web of Science ®Google Scholar
• Gazzieri, D., M. Trevisani, F. Tarantini, P. Bechi, G. Masotti, G. F. Gensini, S. Castellani, N. Marchionni, P. Geppetti, and S. Harrison. 2006. Ethanol dilates coronary arteries and increases coronary flow via transient receptor potential vanilloid 1 and calcitonin gene-related peptide. Cardiovascular Research 70:589–99.
   PubMed Web of Science ®Google Scholar
• Geisel, J., I. Zimbelmann, H. Schorr, J. P. Knapp, M. Bodis, U. Hubner, and W. Herrmann. 2001. Genetic defects as important factors for moderate hyperhomocysteinemia. Clinical Chemistry and Laboratory Medicine 39:698–704.
   PubMed Web of Science ®Google Scholar
• Ghosh, J., G. Joshi, S. Pradhan, and B. Mittal. 2012. Potential role of aromatase over estrogen receptor gene polymorphisms in migraine susceptibility: a case control study from North India. PLOS One 7:e34828.
   PubMed Web of Science ®Google Scholar
• Gonzalez de la Aleja, J., A. Ramos, V. Mato-Abad, A. Martinez-Salio, J. A. Hernandez-Tamames, J. A. Molina, J. Hernandez-Gallego, and J. Alvarez-Linera. 2013. Higher glutamate to glutamine ratios in occipital regions in women with migraine during the interictal state. Headache 53:365–75.
   PubMed Web of Science ®Google Scholar
• Goyette, P., J. S. Sumner, R. Milos, A. M. Duncan, D. S. Rosenblatt, R. G. Matthews, and R. Rozen. 1994. Human methylenetetrahydrofolate reductase: isolation of cDNA mapping and mutation identification. Nature Genetics 7:551.
   PubMed Web of Science ®Google Scholar
• Guo, S., A. L. Esserlind, Z. Andersson, A. L. Frederiksen, J. Olesen, J. Vissing, and M. Ashina. 2016. Prevalence of migraine in persons with the 3243A>G mutation in mitochondrial DNA. European Journal of Neurology 23:175–81.
   PubMed Web of Science ®Google Scholar
• Hamilton, S. P., S. L. Slager, A. B. De Leon, G. A. Heiman, D. F. Klein, S. E. Hodge, M. M. Weissman, A. J. Fyer, and J. A. Knowles. 2004. Evidence for genetic linkage between a polymorphism in the adenosine 2A receptor and panic disorder. Neuropsychopharmacology 29:558–65.
   PubMed Web of Science ®Google Scholar
• Hohoff, C., M. Marziniak, K. P. Lesch, J. Deckert, C. Sommer, and R. Mossner. 2007. An adenosine A2A receptor gene haplotype is associated with migraine with aura. Cephalalgia 27:177–81.
   PubMed Web of Science ®Google Scholar
• iener, H. C., V. Pfaffenrath, L. Pageler, H. Peil, and B. Aicher. 2005. The fixed combination of acetylsalicylic acid, paracetamol and caffeine is more effective than single substances and dual combination for the treatment of headache: a multicentre, randomized, double-blind, single-dose, placebo-controlled parallel group study. Cephalalgia 25:776–87.
   PubMed Web of Science ®Google Scholar
• Jen, J. C., J. Wan, T. P. Palos, B. D. Howard, and R. W. Baloh. 2005. Mutation in the glutamate transporter EAAT1 causes episodic ataxia, hemiplegia, and seizures. Neurology 65:529–34.
   PubMed Web of Science ®Google Scholar
• Joshi, G., S. Pradhan, and B. Mittal. 2010. Role of the oestrogen receptor (ESR1 PvuII and ESR1 325 C->G) and progesterone receptor (PROGINS) polymorphisms in genetic susceptibility to migraine in a North Indian population. Cephalalgia 30:311–20.
   PubMed Web of Science ®Google Scholar
• Kaneko, Y., and A. Szallasi. 2014. Transient receptor potential (TRP) channels: a clinical perspective. British Journal of Pharmacology 171:2474–507.
   PubMed Web of Science ®Google Scholar
• Kaunisto, M. A., M. Kallela, E. Hamalainen, R. Kilpikari, H. Havanka, H. Harno, M. Nissila, E. Sako, M. Ilmavirta, J. Liukkonen, et al. 2006. Testing of variants of the MTHFR and ESR1 genes in 1798 Finnish individuals fails to confirm the association with migraine with aura. Cephalalgia 26:1462–72.
   PubMed Web of Science ®Google Scholar
• Krymchantowski, A. V., and C. da Cunha Jevoux. 2014. Wine and headache. Headache 54:967–75.
   PubMed Web of Science ®Google Scholar
• Lauritzen, M. 1994. Pathophysiology of the migraine aura. The spreading depression theory. Brain 117 (Pt 1):199–210.
   PubMed Web of Science ®Google Scholar
• Lea, R. A., M. Ovcaric, J. Sundholm, J. MacMillan, and L. R. Griffiths. 2004. The methylenetetrahydrofolate reductase gene variant C677T influences susceptibility to migraine with aura. BMC Medicine [Electronic Resource] 2:3.
   PubMed Web of Science ®Google Scholar
• Li, L., R. Liu, Z. Dong, X. Wang, and S. Yu. 2015. Impact of ESR1 Gene Polymorphisms on Migraine Susceptibility: A Meta-Analysis. Medicine 94:e0976.
   PubMed Web of Science ®Google Scholar
• Ligthart, L., B. de Vries, A. V. Smith, M. A. Ikram, N. Amin, J. J. Hottenga, S. C. Koelewijn, V. M. Kattenberg, M. H. de Moor, A. C. Janssens, et al. 2011. Meta-analysis of genome-wide association for migraine in six population-based European cohorts. European Journal of Human Genetics 19(8):901–07.
   PubMed Web of Science ®Google Scholar
• Lippi, G., C. Mattiuzzi, T. Meschi, G. Cervellin, and L. Borghi. 2014. Homocysteine and migraine. A narrative review. Clinica Chimica Acta 433:5–11.
   PubMed Web of Science ®Google Scholar
• Littlewood, J., V. Glover, M. Sandler, R. Petty, R. Peatfield, and F. C. Rose. 1982. Platelet phenolsulphotransferase deficiency in dietary migraine. Lancet 1:983–86.
   PubMed Web of Science ®Google Scholar
• Liu, A., S. Menon, N. J. Colson, S. Quinlan, H. Cox, M. Peterson, T. Tiang, L. M. Haupt, R. A. Lea, and L. R. Griffiths. 2010. Analysis of the MTHFR C677T variant with migraine phenotypes. BMC Res Notes 3:213.
   PubMedGoogle Scholar
• Lorenzo Di, C., F. Pierelli, G. Coppola, G. S. Grieco, C. Rengo, M. Ciccolella, D. Magis, M. Bolla, C. Casali, F. M. Santorelli, and J. Schoenen. 2009. Mitochondrial DNA haplogroups influence the therapeutic response to riboflavin in migraineurs. Neurology 72:1588–94.
   PubMed Web of Science ®Google Scholar
• Maintz, L., C. F. Yu, E. Rodriguez, H. Baurecht, T. Bieber, T. Illig, S. Weidinger, and N. Novak. 2011. Association of single nucleotide polymorphisms in the diamine oxidase gene with diamine oxidase serum activities. Allergy 66:893–902.
   PubMed Web of Science ®Google Scholar
• Markley, H. G. 2012. CoEnzyme Q10 and riboflavin: the mitochondrial connection. Headache 52 (Suppl 2):81–87.
   PubMedGoogle Scholar
• McNulty, H., R. C. Dowey le, J. J. Strain, A. Dunne, M. Ward, A. M. Molloy, L. B. McAnena, J. P. Hughes, M. Hannon-Fletcher, and J. M. Scott. 2006. Riboflavin lowers homocysteine in individuals homozygous for the MTHFR 677C->T polymorphism. Circulation 113:74–80.
   PubMed Web of Science ®Google Scholar
• Menon, S., R. A. Lea, B. Roy, M. Hanna, S. Wee, L. M. Haupt, C. Oliver, and L. R. Griffiths. 2012. Genotypes of the MTHFR C677T and MTRR A66G genes act independently to reduce migraine disability in response to vitamin supplementation. Pharmacogenet Genomics 22:741–49.
   PubMed Web of Science ®Google Scholar
• Metea, M. R., and E. A. Newman. 2006. Glial cells dilate and constrict blood vessels: a mechanism of neurovascular coupling. Journal of Neuroscience 26:2862–70.
   PubMed Web of Science ®Google Scholar
• Mueller, J. W., L. C. Gilligan, J. Idkowiak, W. Arlt, and P. A. Foster. 2015. The Regulation of Steroid Action by Sulfation and Desulfation. Endocrine Reviews 36:526–63.
   PubMed Web of Science ®Google Scholar
• Nagar, S., S. Walther, and R. L. Blanchard. 2006. Sulfotransferase (SULT) 1A1 polymorphic variants *1, *2, and *3 are associated with altered enzymatic activity, cellular phenotype, and protein degradation. Molecular Pharmacology 69:2084–92.
   PubMed Web of Science ®Google Scholar
• Nilius, B., and G. Owsianik. 2011. The transient receptor potential family of ion channels. Genome Biology 12:218.
   PubMed Web of Science ®Google Scholar
• Noseda, R., D. Borsook, and R. Burstein. 2017. Neuropeptides and Neurotransmitters That Modulate Thalamo-Cortical Pathways Relevant to Migraine Headache. Headache 57(Suppl 2):97–111.
   PubMedGoogle Scholar
• Orr, S. L. 2016. Diet and nutraceutical interventions for headache management: A review of the evidence. Cephalalgia 36:1112–33.
   PubMed Web of Science ®Google Scholar
• Oterino, A., J. Pascual, C. Ruiz de Alegria, N. Valle, J. Castillo, Y. Bravo, F. Gonzalez, P. Sanchez-Velasco, A. Cayon, F. Leyva-Cobian, et al. 2006. Association of migraine and ESR1 G325C polymorphism. Neuroreport 17:61–64.
   PubMed Web of Science ®Google Scholar
• Palmirotta, R., P. Barbanti, M. L. De Marchis, G. Egeo, C. Aurilia, L. Fofi, C. Ialongo, M. G. Valente, P. Ferroni, and D. Della-Morte, et al. 2015. Is SOD2 Ala16Val polymorphism associated with migraine with aura phenotype. Antioxid Redox Signal 22:275–79.
   PubMed Web of Science ®Google Scholar
• Palmirotta, R., P. Barbanti, G. Ludovici, G. Egeo, C. Aurilia, L. Fofi, M. L. De Marchis, A. Spila, P. Ferroni, D. Della-Morte, et al. 2013. Establishment of a biorepository for migraine research: the experience of Interinstitutional Multidisciplinary BioBank (BioBIM). Neurological Sciences 34:1659–63.
   PubMed Web of Science ®Google Scholar
• Palmirotta, R., D. Lovero, E. Silvestris, V. Simone, L. Lanotte, D. Quaresmini, and F. Silvestris. 2017. Characterization of a Rare Nonpathogenic Methylenetetrahydrofolatereductase (MTHFR) Gene Mutation p.Lys215del in a Southern Italian family. Human Mutation 38:120–21.
   PubMed Web of Science ®Google Scholar
• Panconesi, A., M. L. Bartolozzi, S. Mugnai, and L. Guidi. 2012. Alcohol as a dietary trigger of primary headaches: what triggering site could be compatible. Neurological Sciences 33(Suppl 1):S203–205.
   PubMedGoogle Scholar
• Peatfield, R. C. 1995. Relationships between food, wine, and beer-precipitated migrainous headaches. Headache 35:355–57.
   PubMed Web of Science ®Google Scholar
• Pistoia, F., S. Sacco, A. Carolei. 2013. Behavioral therapy for chronic migraine. Current Pain and Headache Reports 17(1):304.
   PubMed Web of Science ®Google Scholar
• Preuss, C. V., T. C. Wood, C. L. Szumlanski, R. B. Raftogianis, D. M. Otterness, B. Girard, M. C. Scott, and R. M. Weinshilboum. 1998. Human histamine N-methyltransferase pharmacogenetics: common genetic polymorphisms that alter activity. Molecular Pharmacology 53:708–17.
   PubMed Web of Science ®Google Scholar
• Raftogianis, R. B., T. C. Wood, D. M. Otterness, J. A. Van Loon, and R. M. Weinshilboum. 1997. Phenol sulfotransferase pharmacogenetics in humans: association of common SULT1A1 alleles with TS PST phenotype. Biochemical and Biophysical Research Communications 239:298–304.
   PubMed Web of Science ®Google Scholar
• Ran, C., L. Graae, P. K. Magnusson, N. L. Pedersen, L. Olson, and A. C. Belin. 2014. A replication study of GWAS findings in migraine identifies association in a Swedish case-control sample. BMC Medical Genetics [Electronic Resource] 15:38.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Acevedo, A. J., B. H. Maher, R. A. Lea, M. Benton, and L. R. Griffiths. 2013. Association of oestrogen-receptor gene (ESR1) polymorphisms with migraine in the large Norfolk Island pedigree. Cephalalgia 33:1139–47.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Acevedo, A. J., R. A. Smith, B. Roy, H. Sutherland, R. A. Lea, A. Frith, E. A. MacGregor, and L. R. Griffiths. 2014. Genetic association and gene expression studies suggest that genetic variants in the SYNE1 and TNF genes are related to menstrual migraine. J Headache Pain 15:62.
   PubMedGoogle Scholar
• Rubino, E., M. Ferrero, I. Rainero, E. Binello, G. Vaula, and L. Pinessi. 2009. Association of the C677T polymorphism in the MTHFR gene with migraine: a meta-analysis. Cephalalgia 29:818–25.
   PubMed Web of Science ®Google Scholar
• Saygi, S., I. Erol, F. Alehan, Y. Y. Yalcin, G. Kubat, and F. B. Atac. 2015. Superoxide Dismutase and Catalase Genotypes in Pediatric Migraine Patients. Journal of Child Neurology 30:1586–90.
   PubMed Web of Science ®Google Scholar
• Scharff, L., D. C. Turk, and D. A. Marcus. 1995. Triggers of headache episodes and coping responses of headache diagnostic groups. Headache 35:397–403.
   PubMed Web of Science ®Google Scholar
• Schurks, M., R. Y. Zee, J. E. Buring, and T. Kurth. 2008. Interrelationships among the MTHFR 677C>T polymorphism, migraine, and cardiovascular disease. Neurology 71:505–13.
   PubMed Web of Science ®Google Scholar
• Sebastiao, A. M., and J. A. Ribeiro. 2000. Fine-tuning neuromodulation by adenosine. Trends in Pharmacological Sciences 21:341–46.
   PubMed Web of Science ®Google Scholar
• Seelig, M. S., B. M. Altura, and B. T. Altura. 2004. Benefits and risks of sex hormone replacement in postmenopausal women. Journal of the American College of Nutrition 23:482S–96S.
   PubMed Web of Science ®Google Scholar
• Shin, H. E., S. J. Han, K. S. Lee, and J. W. Park. 2011. Polymorphism of the Glutamate Transporter Protein EAAT2 and Migraine Transformation into Chronic Daily Headache. Journal of Clinical Neurology 7:143–47.
   PubMed Web of Science ®Google Scholar
• Shuen, A. Y., B. Y. Wong, C. Wei, Z. Liu, M. Li, and D. E. Cole. 2009. Genetic determinants of extracellular magnesium concentration: analysis of multiple candidate genes, and evidence for association with the estrogen receptor alpha (ESR1) locus. Clinica Chimica Acta 409:28–32.
   PubMed Web of Science ®Google Scholar
• Silaste, M. L., M. Rantala, M. Sampi, G. Alfthan, A. Aro, and Y. A. Kesaniemi. 2001. Polymorphisms of key enzymes in homocysteine metabolism affect diet responsiveness of plasma homocysteine in healthy women. Journal of Nutrition 131:2643–47.
   PubMed Web of Science ®Google Scholar
• Silberstein, S. D., and D. W. Dodick. 2013. Migraine genetics–a review: Part I. Headache 53:1207–17.
   PubMed Web of Science ®Google Scholar
• Sintas, C., O. Carreno, J. Fernandez-Morales, P. Cacheiro, M. J. Sobrido, B. Narberhaus, P. Pozo-Rosich, A. Macaya, and B. Cormand. 2012. A replication study of a GWAS finding in migraine does not identify association in a Spanish case-control sample. Cephalalgia 32:1076–80.
   PubMed Web of Science ®Google Scholar
• Society, H. C.CotI.H. 2004. The international classification of headache disorder. Cephalalgia 24(suppl 1):1–160.
   Google Scholar
• Sparaco, M., M. Feleppa, R. B. Lipton, A. M. Rapoport, and M. E. Bigal. 2006. Mitochondrial dysfunction and migraine: evidence and hypotheses. Cephalalgia 26:361–72.
   PubMed Web of Science ®Google Scholar
• Stuart, S., H. C. Cox, R. A. Lea, and L. R. Griffiths. 2012. The role of the MTHFR gene in migraine. Headache 52:515–20.
   PubMed Web of Science ®Google Scholar
• Taylor, F. R. 2011. Nutraceuticals and headache: the biological basis. Headache 51:484–501.
   PubMed Web of Science ®Google Scholar
• Teigen, L., and C. J. Boes. 2015. An evidence-based review of oral magnesium supplementation in the preventive treatment of migraine. Cephalalgia 35:912–22.
   PubMed Web of Science ®Google Scholar
• Thomae, B. A., O. F. Rifki, M. A. Theobald, B. W. Eckloff, E. D. Wieben, and R. M. Weinshilboum. 2003. Human catecholamine sulfotransferase (SULT1A3) pharmacogenetics: functional genetic polymorphism. Journal of Neurochemistry 87:809–19.
   PubMed Web of Science ®Google Scholar
• Tuncel, D., F. I. Tolun, M. Gokce, S. Imrek, and H. Ekerbicer. 2008. Oxidative stress in migraine with and without aura. Biological Trace Element Research 126:92–97.
   PubMed Web of Science ®Google Scholar
• Uncini, A., R. Lodi, A. Di Muzio, G. Silvestri, S. Servidei, A. Lugaresi, S. Iotti, P. Zaniol, and B. Barbiroli. 1995. Abnormal brain and muscle energy metabolism shown by 31P-MRS in familial hemiplegic migraine. Journal of the Neurological Sciences 129:214–22.
   PubMed Web of Science ®Google Scholar
• Volinsky, R., and P. K. Kinnunen. 2013. Oxidized phosphatidylcholines in membrane-level cellular signaling: from biophysics to physiology and molecular pathology. The Febs Journal 280:2806–16.
   PubMed Web of Science ®Google Scholar
• Wang, Q., M. Ito, K. Adams, B. U. Li, T. Klopstock, A. Maslim, T. Higashimoto, J. Herzog, and R. G. Boles. 2004. Mitochondrial DNA control region sequence variation in migraine headache and cyclic vomiting syndrome. American Journal of Medical Genetics. Part A 131:50–58.
   PubMed Web of Science ®Google Scholar
• Wilson, C. W., J. G. Kirker, H. Warnes, and M. O'Malley. 1980. The clinical features of migraine as a manifestation of allergic disease. Postgraduate Medical Journal 56:617–21.
   PubMed Web of Science ®Google Scholar
• Woodbridge, P., C. Liang, R. L. Davis, H. Vandebona, and C. M. Sue. 2013. POLG mutations in Australian patients with mitochondrial disease. Internal Medicine Journal 43:150–56.
   PubMed Web of Science ®Google Scholar
• Yildirim, S., S. Akar, M. Kuyucu, A. Yildirim, S. Dane, and R. Aygul. 2011. Paraoxonase 1 gene polymorphisms, paraoxonase/arylesterase activities and oxidized low-density lipoprotein levels in patients with migraine. Cell Biochemistry and Function 29:549–54.
   PubMed Web of Science ®Google Scholar
• Zivadinov, R., K. Willheim, D. Sepic-Grahovac, A. Jurjevic, M. Bucuk, O. Brnabic-Razmilic, G. Relja, and M. Zorzon. 2003. Migraine and tension-type headache in Croatia: a population-based survey of precipitating factors. Cephalalgia 23:336–43.
   PubMed Web of Science ®Google Scholar